EBIT Margin: Earnings before interest and taxes as a portion of total revenues. Calculated as: EBIT / Total Revenues
Corbus Pharmaceuticals Holdings, Inc. (CRBP) EBIT Margin data is not available for the most recently reported fiscal quarter, ending 2025-09-30.
| Income Statement Financials | |
-- |
|
$-23.34M |
|
-- |
|
-- |
|
$24.42M |
|
$-24.42M |
|
$1.07M |
|
$-23.34M |
|
$-23.34M |
|
$-23.34M |
|
$-23.34M |
|
$-23.34M |
|
$-23.34M |
|
$-24.42M |
|
$-24.42M |
|
12.31M |
|
12.31M |
|
$-1.90 |
|
$-1.90 |
|
| Balance Sheet Financials | |
$107.57M |
|
$0.20M |
|
$1.94M |
|
$109.51M |
|
$17.06M |
|
-- |
|
$0.31M |
|
$17.37M |
|
$92.15M |
|
$92.15M |
|
$92.15M |
|
12.54M |
|
| Cash Flow Statement Financials | |
$-48.57M |
|
$55.50M |
|
$2.85M |
|
$17.87M |
|
$27.65M |
|
$9.79M |
|
$4.86M |
|
-- |
|
-- |
|
| Fundamental Metrics & Ratios | |
6.31 |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
|
EBIT Margin |
-- |
-- |
|
-- |
|
-- |
|
$-48.57M |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-25.33% |
|
-25.33% |
|
-21.31% |
|
-25.33% |
|
$7.35 |
|
$-3.95 |
|
$-3.95 |
|